Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-049370

CHAIRMAN AND CEO bought 1,356,990 shares at an average $0.02 ($23,537)

From the SEC's structured data for this filing

Trades in this filing

Trieu Vuong · CHAIRMAN AND CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-29 Purchase : show line 1 in the form +1,044,990 $0.02 $17,765 95,481,309 D
2026-10-28 Purchase : show line 2 in the form +312,000 $0.02 $5,772 94,436,319 D
Open-market purchases · 1,356,990 sh · avg $0.02 · $23,537
Loading xslF345X06/ownership.xml…